Condition: Breast Cancer · Hematologic Malignancy · Immune Checkpoint Inhibitor-Related Myocarditis · Sponsor: The Cleveland Clinic
G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.
This description comes directly from the study's public registry record.
Diego Sadler, MD FACC · 5613898833 · sadlerd@ccf.org
Rohit Moudgil, MD PhD · 216-445-1932 · moudgir@ccf.org
Always discuss trial participation with your own doctor first.
| Cleveland Clinic Florida | Weston, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05598879